We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.11% as an Perm industry with 58 employees hired as of 2024


Top In-Vitro Diagnostic Substance Manufacturing Employers

Company Employees Average Wage
Indivior, Inc. 1 $45,885
Caredx 1 $235,893
Diasorin Inc. 1 $152,568
Microbiologics, Inc. 1 $74,568
Linzhi International, Inc. 1 $76,794
Zepto Life Technology, Llc 1 $88,982
Immunomycologics, Inc.; D.b.a. Immy 1 $35,235
Syntron Bioresearch, Inc. 1 $61,901
Luminex Corporation 1 $119,267


Top In-Vitro Diagnostic Substance Manufacturing Jobs

Job Title Number of Jobs Average Wage
Medical Scientists, Except Epidemiologists 4 $46,842
Biochemists And Biophysicists 3 $67,281
Software Developers, Applications 3 $90,043
Mechanical Engineers 2 $44,512
Microbiologists 2 $53,810
Compliance Officers 2 $78,697
General And Operations Managers 2 $135,918
Chemists 2 $69,212
Physicists 1 $47,237
Biomedical Engineers 1 $77,397

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2010 where 1 employees were hired. They peaked in 2018 with 5 employees, and have since been on a decline with the most recent number of employees being 3 in 2023.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2010 where the average salary was $47,237. The industry peaked in 2019 with an average salary of $118,019, and has since been on a decline with the most recent average salary being $72,134 in 2023.